Daubert standard

Daubert standard The Daubert standard is a judicially created rule used by United States trial courts to assess the admissibility of expert scientific testimony, arising from a Supreme Court decision that interpreted the Federal Rules of Evidence. It reshaped the gatekeeping role of trial judges and influenced litigation across federal and state jurisdictions, affecting how courts evaluate scientific validity, methodological reliability, and relevance in complex matters before juries and judges.

Background and legal foundation

The decision originated in a case involving Purdue Pharma litigation over pharmaceuticals and was decided by the United States Supreme Court in 1993, authored by Justice Harry Blackmun. It interpreted Federal Rules of Evidence Rule 702 and supplanted the earlier standard articulated in Frye v. United States from 1923. The opinion followed appellate practice from the United States Court of Appeals for the Ninth Circuit and engaged with precedent including Kumho Tire Co. v. Carmichael and later applied alongside decisions such as General Electric Co. v. Joiner. The ruling influenced procedures in trial courts overseen by judges appointed by presidents like Bill Clinton and confirmed by the United States Senate, and it interacted with statutory frameworks shaped during congressional sessions and committee work in the United States Congress.

Criteria and factors for admissibility

Daubert set out a non-exhaustive list of factors for assessing scientific expert testimony: whether the theory or technique can be (and has been) tested, whether it has been subjected to peer review and publication, the known or potential error rate, the existence and maintenance of standards controlling the technique’s operation, and general acceptance within a relevant scientific community. Courts often examine literature from journals such as The New England Journal of Medicine, Science, Nature, and citations involving researchers affiliated with institutions like Harvard University, Stanford University, Massachusetts Institute of Technology, Johns Hopkins University, and University of California, Berkeley. Judges may consider reports from agencies such as the Food and Drug Administration and analyses by organizations like the National Academy of Sciences, while expert credentials frequently trace to entities such as Columbia University, Yale University, University of Chicago, University of Pennsylvania, and California Institute of Technology.

Application in federal and state courts

Federal trial courts operating under the United States District Court system apply Daubert when evaluating expert testimony in federal question and diversity cases, with appellate review by the United States Courts of Appeals and potential certiorari to the United States Supreme Court. After Daubert, many state judiciaries adopted similar gatekeeping approaches through state high courts such as the California Supreme Court, New York Court of Appeals, Texas Supreme Court, Florida Supreme Court, and Ohio Supreme Court, while some states retained or modified Frye-type standards via decisions from courts like the Massachusetts Supreme Judicial Court and the Illinois Supreme Court. Application has varied in contexts including product liability suits involving companies like Johnson & Johnson and Merck & Co., toxic tort litigation concerning events such as the Love Canal controversy, environmental disputes referencing Environmental Protection Agency findings, and criminal cases addressing forensic techniques once used by agencies like the Federal Bureau of Investigation.

Impact on expert testimony and litigation practice

The decision produced substantial changes in how litigators prepare expert disclosures and Daubert motions, affecting practices of law firms such as Skadden, Arps, Slate, Meagher & Flom and boutique firms handling mass torts associated with corporations like Monsanto and Dow Chemical Company. Experts from scientific centers including Rochester Institute of Technology, University of Michigan, Duke University, Northwestern University, and Brown University now undergo greater scrutiny about methodology and publication record. Trial judges trained at institutions like National Judicial College and appellate judges from circuits influenced litigation strategy, prompting increased use of litigation funding, consulting firms, and jury consultants such as those affiliated with Kroll or The Nielsen Company. The ruling also affected regulatory litigation involving agencies such as the Centers for Disease Control and Prevention and influenced scholarly discussion in journals published by Oxford University Press and Cambridge University Press.

Criticisms and scholarly debate

Scholars, jurists, and practitioners have debated whether the standard promotes sound science or produces gatekeeping that disadvantages plaintiffs and strains judicial resources. Critiques have appeared in law reviews from schools such as Harvard Law School, Yale Law School, Columbia Law School, Stanford Law School, and New York University School of Law, and in interdisciplinary forums connecting to work at Brookings Institution, American Enterprise Institute, Hoover Institution, and Brennan Center for Justice. Empirical studies conducted by researchers at National Bureau of Economic Research, RAND Corporation, and university centers have examined effects on case outcomes in jurisdictions including California, Texas, New York, and Florida. Debates engage prominent figures from courts and academia, including commentators associated with Antonin Scalia, Ruth Bader Ginsburg, Sandra Day O'Connor, Stephen Breyer, and legal scholars such as Richard Posner and Cass Sunstein, reflecting ongoing contention over balancing scientific rigor with access to the civil and criminal justice systems.

Category:United States evidence law